Zhejiang Garden Biopharmaceutical Co., Ltd. (300401) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Garden Biopharmaceutical Co., Ltd.

Why is Zhejiang Garden Biopharmaceutical Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 11.18% and Operating profit at 3.71% over the last 5 years

With a fall in Net Sales of -15.17%, the company declared Very Negative results in Mar 26

INTEREST(HY) At CNY 16.32 MM has Grown at 5.93%
ROCE(HY) Lowest at 7.51%
INTEREST COVERAGE RATIO(Q) Lowest at 896.17

With ROE of 7.22%, it has a expensive valuation with a 1.63 Price to Book Value

Over the past year, while the stock has generated a return of 44.04%, its profits have fallen by -18.3%
At the current price, the company has a high dividend yield of 1.1

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zhejiang Garden Biopharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Garden Biopharmaceutical Co., Ltd.

16.08%

1.82

51.14%

China Shanghai Composite

3.23%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.18%

EBIT Growth (5y)

3.71%

EBIT to Interest (avg)

12.82

Debt to EBITDA (avg)

1.22

Net Debt to Equity (avg)

0.12

Sales to Capital Employed (avg)

0.23

Tax Ratio

13.04%

Dividend Payout Ratio

20.14%

Pledged Shares

Institutional Holding

ROCE (avg)

10.28%

ROE (avg)

12.07%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

3.46

EV to EBIT

39.99

EV to EBITDA

28.08

EV to Capital Employed

3.23

EV to Sales

10.61

PEG Ratio

Dividend Yield

0.51%

ROCE (Latest)

8.06%

ROE (Latest)

7.22%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

INTEREST COVERAGE RATIO(Q)

Highest at 1,917.56

INVENTORY TURNOVER RATIO(HY)

Highest at 0.91 times

NET SALES(Q)

Highest at CNY 415.22 MM

OPERATING PROFIT(Q)

Highest at CNY 144.53 MM

PRE-TAX PROFIT(Q)

Highest at CNY 92.47 MM

NET PROFIT(Q)

Highest at CNY 81.65 MM

EPS(Q)

Highest at CNY 0.14

-4What is not working for the Company

ROCE(HY)

Lowest at 7.95%

RAW MATERIAL COST(Y)

Grown by 21.95% (YoY

OPERATING PROFIT MARGIN(Q)

Lowest at 34.81 %

Here's what is working for Zhejiang Garden Biopharmaceutical Co., Ltd.

Interest Coverage Ratio

Highest at 1,917.56

in the last five periods

MOJO Watch

The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales

Highest at CNY 415.22 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Net Sales

At CNY 415.22 MM has Grown at 34.39%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY 144.53 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit

Highest at CNY 92.47 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 81.65 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.14

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio

Highest at 0.91 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Here's what is not working for Zhejiang Garden Biopharmaceutical Co., Ltd.

Operating Profit Margin

Lowest at 34.81 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Raw Material Cost

Grown by 21.95% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales